The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 31, 2017

Filed:

Feb. 22, 2016
Applicant:

Rush University Medical Center, Chicago, IL (US);

Inventor:

Marvin A. Rossi, Chicago, IL (US);

Assignee:

Rush University Medical Center, Chicago, IL (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61N 1/365 (2006.01); A61N 1/362 (2006.01); B82Y 5/00 (2011.01); A61N 1/372 (2006.01); A61N 1/00 (2006.01); A61N 1/20 (2006.01); B82Y 30/00 (2011.01); A61N 1/36 (2006.01); A61N 1/32 (2006.01);
U.S. Cl.
CPC ...
A61N 1/37205 (2013.01); A61N 1/00 (2013.01); A61N 1/205 (2013.01); A61N 1/362 (2013.01); A61N 1/365 (2013.01); A61N 1/36064 (2013.01); A61N 1/36135 (2013.01); B82Y 30/00 (2013.01); A61N 1/325 (2013.01); A61N 1/327 (2013.01);
Abstract

An energy-releasing carbon nanotube transponder comprising a nanocapacitor connected to at least one carbon nanotube and method of using same are described. An adjustable amount of electric energy is stored within the nanocapacitor so that the energy-releasing carbon nanotube transponder delivers either a biologically destructive or a biologically non-destructive electrical charge to target cells in response to biological, chemical or electrical stimuli. An optional biocompatible coating onto the outer surface of the carbon nanotube transponder improves cellular targeting, cellular binding or body tolerance towards the carbon nanotube transponder. Optionally, a molecular label attached to at least one carbon nanotube allows for in vivo tracking of the carbon nanotube transponder. The targeted release of electric energy from the carbon nanotube transponder can, for example, destroy cancer cells in cancer patients, or control the flux of electric wave within a cellular tissue to treat cardiac and/or epileptic patients.


Find Patent Forward Citations

Loading…